XOMA

XOMA Royalty Corp

Nasdaq · Pharmaceutical Preparations · Inc. NV · CIK 0000791908
$41.79 -0.02% $524.1M
High Impact Filing (8/10)4 New Institutional Positions
Vol
Market Cap$524.1M
Cap SizeSmall Cap
Analyst ConsensusBuy (67%)
Inst. Holders41 funds
Inst. Value$179.1M
Inst. Activity4 buys / 2 sells
SEC Reports3
Press Releases3
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. NV·CIK 0000791908·Prev Close $41.80

Recent Activity

Jun 12, 2026 SEC
XOMA Royalty Corp filed additional definitive proxy soliciting materials (DEFA14A) confirming its acquisition by Ligand
DEFA14A — Impact 8/10
Jun 12, 2026 SEC
XOMA Royalty Corp announced that the previously announced acquisition by Ligand Pharmaceuticals is expected to close on
8-K — Impact 4/10
Jun 12, 2026 dividend
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date
<p align="justify">EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation
May 21, 2026 Insider
LIMBER JOSEPH M was granted 3,586 shares
Director
May 21, 2026 Insider
Kosacz Barbara was granted 3,586 shares
Director
May 21, 2026 Insider
Franklin Heather L was granted 3,586 shares
Director
Mar 18, 2026 SEC
Analysis based on filing metadata only — document content was unavailable. The 8-K filing includes Items 2.02 (Results o
8-K — Impact 4/10
Inst.
Woodline Partners LP — DOUBLED
640,001 shares ($20.1M)

Price Targets

$39.00 -6.7% upside Sell
Current $41.79 Low $39.00 Median $39.00 High $39.00 1 analysts
$39.00 $39.00

Analyst Ratings

Buy67% buy · 9 analysts
2Strong Buy
4Buy
3Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
Apr 30, 2026 HC Wainwright & Co. DOWNGRADE Buy → Neutral
Mar 20, 2026 HC Wainwright & Co. REITERATE Buy → Buy
Feb 24, 2026 Leerink Partners MAINTAIN Outperform → Outperform

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $0.17 ▼ -23.1% $-0.15 — $0.50 -60% YoY 2
Next Q $0.26 ▼ -32.0% $0.00 — $0.52 -63% YoY 2
Current FY $0.79 ▼ -28.6% $-0.25 — $2.06 -46% YoY 3
Next FY $-0.05 ▼ -107.3% $-0.05 — $-0.05 -106% YoY 1

Latest Reports

BULLISH DEFA14A 8/10
XOMA Royalty Corp filed additional definitive proxy soliciting materials (DEFA14A) confirming its acquisition by Ligand
Jun 12, 2026
NEUTRAL 8-K 4/10
XOMA Royalty Corp announced that the previously announced acquisition by Ligand Pharmaceuticals is expected to close on
Jun 12, 2026
NEUTRAL Press 3/10
XOMA Royalty Corporation declared quarterly cash dividends for its Series A and Series B Cumulative Preferred Stock, wit
Mar 18, 2026

Top Institutional Holders

FundValueMove
MORGAN STANLEY$53.4MDOUBLED
FMR LLC$40.9M—
BlackRock, Inc.$20.3M—
Woodline Partners LP$20.1MDOUBLED
VANGUARD CAPITAL MANAGEMENT LLC$17.2M—

Recent Insider Trades

DateInsiderTypeValue
May 21, 2026LIMBER JOSEPHA$0.00
May 21, 2026Kosacz BarbaraA$0.00
May 21, 2026Franklin HeatherA$0.00
May 21, 2026PERRY MATTHEWA$0.00
May 21, 2026Hernday NatashaA$0.00
41 institutional holders with $179.1M total value (5,716,247 shares) as of 2026-Q1. Top holders: MORGAN, FMR, BlackRock,. Net buying activity: 4 institutions added/increased vs 2 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1MORGAN STANLEY1,702,157$53.4M29.8%DOUBLED +253.7%
2FMR LLC1,302,974$40.9M22.8%—
3BlackRock, Inc.646,914$20.3M11.3%—
4Woodline Partners LP640,001$20.1M11.2%DOUBLED +143.4%
5VANGUARD CAPITAL MANAGEMENT LLC549,796$17.2M9.6%—
6STATE STREET CORP193,148$6.1M3.4%—
7DIMENSIONAL FUND ADVISORS LP133,360$4.2M2.3%DOUBLED +207.7%
8CITADEL ADVISORS LLC98,638$3.1M1.7%—
9VANGUARD PORTFOLIO MANAGEMENT LLC85,797$2.7M1.5%—
10VANGUARD FIDUCIARY TRUST CO66,664$2.1M1.2%—
11PANAGORA ASSET MANAGEMENT INC58,662$1.8M1.0%DOUBLED +176.3%
12STATE OF WISCONSIN INVESTMENT BOARD28,894$906.4K0.5%—
13CHARLES SCHWAB INVESTMENT MANAGEMENT INC27,151$851.7K0.5%—
14TWO SIGMA INVESTMENTS, LP26,075$818.0K0.5%—
15GOLDMAN SACHS GROUP INC23,998$752.8K0.4%—
16SUSQUEHANNA INTERNATIONAL GROUP, LLP17,390$545.5K0.3%—
17ExodusPoint Capital Management, LP14,663$460.0K0.3%—
18Nuveen, LLC12,706$398.6K0.2%—
19RHUMBLINE ADVISERS11,705$367.2K0.2%—
20CITADEL ADVISORS LLC11,600$363.9K0.2%—

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
Woodline Partners LPDOUBLED262,933640,001+143.4%$20.1M2026-Q1
DIMENSIONAL FUND ADVISORS LPDOUBLED43,335133,360+207.7%$4.2M2026-Q1
PANAGORA ASSET MANAGEMENT INCDOUBLED21,22958,662+176.3%$1.8M2026-Q1
DEUTSCHE BANK AG\DOUBLED1248,447+6712.1%$265.0K2026-Q1
LOS ANGELES CAPITAL MANAGEMENT LLCNEAR_EXIT19,332190-99.0%$6.0K2026-Q1
Allworth Financial LPTRIM103-70.0%$95.002026-Q1
Woodline Partners LPADD209,945262,933+25.2%$7.0M2025-Q4
DIMENSIONAL FUND ADVISORS LPADD29,19043,335+48.5%$1.2M2025-Q4
RENAISSANCE TECHNOLOGIES LLCADD28,90039,017+35.0%$1.0M2025-Q4
LOS ANGELES CAPITAL MANAGEMENT LLCADD14,67619,332+31.7%$642.2K2025-Q4
BANK OF AMERICA CORP /DE/DOUBLED3,95511,942+201.9%$317.5K2025-Q4
WELLS FARGO & COMPANY/MNADD6,47710,755+66.0%$286.0K2025-Q4
FEDERATED HERMES, INC.ADD227335+47.6%$8.9K2025-Q4
PNC FINANCIAL SERVICES GROUP, INC.DOUBLED725+257.1%$666.002025-Q4
RENAISSANCE TECHNOLOGIES LLCDOUBLED11,90028,900+142.9%$1.1M2025-Q3
MACQUARIE GROUP LTDDOUBLED3,4666,932+100.0%$221.0K2025-Q3
UBS Group AGTRIM16,1104,151-74.2%$160.0K2025-Q3
Russell Investments Group, Ltd.DOUBLED22778+3436.4%$30.0K2025-Q3
NATIXISTRIM1,462372-74.6%$14.3K2025-Q3
PNC FINANCIAL SERVICES GROUP, INC.DOUBLED27+250.0%$271.002025-Q3
CWM, LLCADD120152+26.7%$6.002025-Q3
VANGUARD GROUP INCADD459,088638,813+39.1%$16.1M2025-Q2
DIMENSIONAL FUND ADVISORS LPADD21,88227,921+27.6%$705.8K2025-Q2
UBS Group AGDOUBLED4,83316,110+233.3%$406.0K2025-Q2
NISA INVESTMENT ADVISORS, LLCDOUBLED819+137.5%$479.002025-Q2
11 unique insiders with 24 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 21, 2026LIMBER JOSEPH MDirectorAWARD3,586——
May 21, 2026Kosacz BarbaraDirectorAWARD3,586——
May 21, 2026Franklin Heather LDirectorAWARD3,586——
May 21, 2026PERRY MATTHEW DDirectorAWARD3,586——
May 21, 2026Hernday NatashaDirectorAWARD3,586——
May 21, 2026WYSZOMIERSKI JACK LDirectorAWARD3,586——
May 14, 2026BVF PARTNERS L P/IL10%+ OwnerCONVERT2,313,000$4.03$9.3M
May 14, 2026BVF PARTNERS L P/IL10%+ OwnerCONVERT2,313——
Apr 20, 2026Trigilio JeffreyChief Financial OfficerEXERCISE11,538——
Apr 20, 2026Montano Maricel PereaChief Legal OfficerEXERCISE3,370——
Apr 20, 2026Hughes OwenChief Executive OfficerEXERCISE10,568——
Apr 20, 2026Sitko BradleyChief Investment OfficerEXERCISE3,737——
Apr 13, 2026Trigilio JeffreyChief Financial OfficerEXERCISE4,000——
Apr 13, 2026Trigilio JeffreyChief Financial OfficerTAX W/H1,632$36.76$60.0K
Mar 27, 2026LIMBER JOSEPH MDirectorEXERCISE3,026$11.20$33.9K
Mar 24, 2026WYSZOMIERSKI JACK LDirectorEXERCISE3,026$11.20$33.9K
Mar 16, 2026Hughes OwenChief Executive OfficerAWARD82,428——
Mar 16, 2026Hughes OwenChief Executive OfficerAWARD126,813——
Mar 11, 2026Montano Maricel PereaChief Legal OfficerAWARD26,289——
Mar 11, 2026Trigilio JeffreyChief Financial OfficerAWARD90,000——
Mar 11, 2026Sitko BradleyChief Investment OfficerAWARD44,849——
Mar 11, 2026Montano Maricel PereaChief Legal OfficerAWARD40,444——
Mar 11, 2026Trigilio JeffreyChief Financial OfficerAWARD138,462——
Mar 11, 2026Sitko BradleyChief Investment OfficerAWARD30,000——
3 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 5.3/10.
BULLISH DEFA14A 8/10
XOMA Royalty Corp filed additional definitive proxy soliciting materials (DEFA14A) confirming its ac
Jun 12, 2026
NEUTRAL 8-K 4/10
XOMA Royalty Corp announced that the previously announced acquisition by Ligand Pharmaceuticals is e
Jun 12, 2026
NEUTRAL 8-K 4/10
Analysis based on filing metadata only — document content was unavailable. The 8-K filing includes I
Mar 18, 2026
NEUTRAL 3/10
XOMA Royalty Corporation declared quarterly cash dividends for its Series A and Series B Cumulative
Mar 18, 2026
BULLISH 8/10
XOMA Royalty Corporation reported strong full-year 2025 financial results with revenue up 83% YoY to
Mar 18, 2026
NEUTRAL 3/10
XOMA Royalty Corporation announced it will report its fourth quarter and full year 2025 financial re
Mar 12, 2026
Current analyst consensus: Buy (67% buy). Based on 9 analysts: 2 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$39.00 mean target -6.7% upside Sell (3.00)
$39.00 Low $39.00 High
MetricValue
Current Price$41.79
Target Low$39.00
Target Mean$39.00
Target Median$39.00
Target High$39.00
# Analysts1
RecommendationSell (3.00)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
 $0.17 $-0.15 $0.50 -60.2% -23.1% 0↑ 1↓ $0.0B 5.9% 2
Next Q
2026-09-30
 $0.26 $0.00 $0.52 -62.9% -32.0% 0↑ 1↓ $0.0B 60.5% 2
Current FY
2026-12-31
 $0.79 $-0.25 $2.06 -46.1% -28.6% 2↑ 1↓ $0.1B 16.5% 3
Next FY
2027-12-31
 $-0.05 $-0.05 $-0.05 -106.4% -107.3% 1↑ 1↓ $0.1B -13.6% 1

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$0.175
7d ago$0.213-0.038
30d ago$0.228-0.053
60d ago$0.075+0.100
90d ago$0.075+0.100
2 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Apr 30, 2026 HC Wainwright & Co. DOWNGRADE Buy Neutral
Mar 20, 2026 HC Wainwright & Co. REITERATE Buy Buy
Feb 24, 2026 Leerink Partners MAINTAIN Outperform Outperform

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20262430067%
May 1, 20262440060%
Apr 1, 20263620082%
Mar 1, 20263620082%
Feb 1, 20263610090%
Jan 1, 20263610090%
Strong BuyBuyHoldSellStrong Sell
∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

∅

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 12, 2026
dividend
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date
<p align="justify">EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“<strong>XOMA</strong>” or the “<s
Apr 30, 2026
earnings_calendar
XOMA Q1 2026 Earnings Scheduled — 2026-04-30
Apr 28, 2026
short_interest
FTD: XOMA — 67,191 shares ($2.8M) failed to deliver
Settlement: 20260428, Price: $41.97, FTD Value: $2,820,006.27, XOMA ROYALTY CORPORATION COMMO
Mar 18, 2026
dividend
XOMA Royalty Declares Quarterly Preferred Stock Dividends
April 2026 dividend record date
Mar 18, 2026
earnings
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements
<p align="center"><strong><em>Portfolio receipts</em></strong><em>: • Achieved over $50 million of cash receipts, including $33.6 million in royalties
Mar 18, 2026
earnings_calendar
XOMA Q4 2025 Earnings Before Market Open — 2026-03-18
Mar 13, 2026
earnings_calendar
XOMA Q4 2025 Earnings Before Market Open — 2026-03-13
Mar 12, 2026
earnings
XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
XOMA Royalty will conduct a webcast to review 4Q and full year 2025 financial results
Mar 5, 2026
earnings_calendar
XOMA Q4 2025 Earnings Before Market Open — 2026-03-05